4341 – 4350 of 4410
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.
- Contribution to journal › Article
-
Mark
Tracking differentiating neural progenitors in pluripotent cultures using microRNA-regulated lentiviral vectors.
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.
- Contribution to journal › Article
-
Mark
Functional properties of the human ventral mesencephalic neural stem cell line hVM1.
- Contribution to journal › Article
-
Mark
Gene therapy for Parkinson's disease.
- Contribution to journal › Article
-
Mark
The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia.
- Contribution to journal › Article
-
Mark
GABAergic Differentiation Induced by Mash1 Is Compromised by the bHLH Proteins Neurogenin2, NeuroD1, and NeuroD2.
- Contribution to journal › Article
-
Mark
Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease.
- Contribution to journal › Article
-
Mark
Effects of Method of Translation of Patient-Reported Health Outcome Questionnaires: A Randomized Study of the Translation of the Rheumatoid Arthritis Quality of Life (RAQoL) Instrument for Sweden.
- Contribution to journal › Article
-
Mark
Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease.
- Contribution to journal › Article
